Biotech Values

[DewDiligence]

Re: IDIX royalty income

Do you have any ideas what the NVS royalties could amount to, roughly?

On today’s CC, the CFO said IDIX expects royalty income of approximately $4M for 2009, which is less than the $10M annual figure I mentioned in #msg-32683976. The difference is not due to declining sales of Tyzeka but rather to my having screwed up by overlooking that the revenue line in IDIX’s income statement includes amortization of milestone payments previously received from NVS and does not consist solely of royalty income.